Shafirstein Gal, Bellnier David, Oakley Emily, Hamilton Sasheen, Potasek Mary, Beeson Karl, Parilov Evgueni
Photodynamic Therapy Center, Department of Cell Stress Biology, Roswell Park Cancer Institute (RPCI), Elm & Carlton Streets, Buffalo, NY 14263, USA.
Simphotek, Inc., 211 Warren St, Newark, NJ 07103, USA.
Cancers (Basel). 2017 Jan 24;9(2):12. doi: 10.3390/cancers9020012.
Multiple clinical studies have shown that interstitial photodynamic therapy (I-PDT) is a promising modality in the treatment of locally-advanced cancerous tumors. However, the utilization of I-PDT has been limited to several centers. The objective of this focused review is to highlight the different approaches employed to administer I-PDT with photosensitizers that are either approved or in clinical studies for the treatment of prostate cancer, pancreatic cancer, head and neck cancer, and brain cancer. Our review suggests that I-PDT is a promising treatment in patients with large-volume or thick tumors. Image-based treatment planning and real-time dosimetry are required to optimize and further advance the utilization of I-PDT. In addition, pre- and post-imaging using computed tomography (CT) with contrast may be utilized to assess the response.
多项临床研究表明,间质光动力疗法(I-PDT)在治疗局部晚期癌性肿瘤方面是一种很有前景的治疗方式。然而,I-PDT的应用仅限于少数几个中心。本重点综述的目的是强调在使用已获批或正在进行治疗前列腺癌、胰腺癌、头颈癌和脑癌临床研究的光敏剂进行I-PDT治疗时所采用的不同方法。我们的综述表明,I-PDT对于大体积或厚肿瘤患者是一种有前景的治疗方法。需要基于图像的治疗计划和实时剂量测定来优化并进一步推进I-PDT的应用。此外,可利用使用对比剂的计算机断层扫描(CT)进行成像前后检查来评估治疗反应。